HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.

AbstractPURPOSE:
Our aim was to determine the non-inferiority of normal saline flushing compared to heparin flushing in maintaining the patency of totally implanted venous access devices (TIVADs).
METHOD:
Four hundred and thirty patients were recruited from 14 Italian centres. Patients were randomized to heparin group or to normal saline group. The primary outcome of the study was TIVAD occlusion.
RESULTS:
After randomisation, 203 patients were assigned to normal saline group and 212 to heparin group. Median follow up time was 204 days in normal saline group and 294 in the heparin group. We observed 24 withdrawal occlusions (5.78%): 10 in the heparin group and 14 in the normal saline group. One total occlusion was observed in the normal saline group. Taking as reference the arm treated with heparin, the absolute risk difference was 2.67 with the 90% CI including the non - inferiority margin of 4%. No significant difference between hazards of occlusion was found.
CONCLUSIONS:
This study failed to demonstrate that normal saline flushing is not inferior to heparin flushing, even if a significant difference between the two treatments was not found. The use of heparin is controversial and other prospective trials are necessary in this field.
TRIAL REGISTRATION:
EudraCT number: 2009-013620-22.
AuthorsAlberto Dal Molin, Mario Clerico, Michela Baccini, Linda Guerretta, Barbara Sartorello, Laura Rasero
JournalEuropean journal of oncology nursing : the official journal of European Oncology Nursing Society (Eur J Oncol Nurs) Vol. 19 Issue 6 Pg. 638-43 (Dec 2015) ISSN: 1532-2122 [Electronic] Scotland
PMID25933709 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Sodium Chloride
  • Heparin
Topics
  • Adult
  • Aged
  • Ambulatory Care Facilities
  • Antineoplastic Agents (administration & dosage)
  • Catheter Obstruction
  • Catheterization, Central Venous (adverse effects, methods)
  • Catheters, Indwelling
  • Female
  • Heparin (pharmacology)
  • Humans
  • Infusions, Intravenous
  • Italy
  • Male
  • Middle Aged
  • Neoplasms (drug therapy, pathology)
  • Outpatients (statistics & numerical data)
  • Prognosis
  • Proportional Hazards Models
  • Sodium Chloride (pharmacology)
  • Treatment Outcome
  • Vascular Patency (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: